{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T05:40:30Z","timestamp":1785735630426,"version":"3.56.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"DOI":"10.1186\/s12877-024-05515-y","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T08:30:24Z","timestamp":1731745824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Adverse drug reactions and its associated factors among geriatric hospitalized patients at selected comprehensive specialized hospitals of the Amhara Region, Ethiopia: a multicenter prospective cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Samuel Berihun","family":"Dagnew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilaye Arega","family":"Moges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teklie Mengie","family":"Ayele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Agegnew","family":"Wondm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taklo Simeneh","family":"Yazie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fisseha Nigussie","family":"Dagnew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"issue":"2","key":"5515_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jsps.2013.02.003","volume":"22","author":"MJ Alomar","year":"2014","unstructured":"Alomar MJ. Factors affecting the development of adverse drug reactions. Saudi Pharm J. 2014;22(2):83\u201394.","journal-title":"Saudi Pharm J"},{"key":"5515_CR2","doi-asserted-by":"crossref","unstructured":"Hadi MA et al. Pharmacovigilance: pharmacists\u2019 perspective on spontaneous adverse drug reaction reporting. Integr Pharm Res Pract, 2017: pp. 91\u20138.","DOI":"10.2147\/IPRP.S105881"},{"issue":"1","key":"5515_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/bmb\/ldm016","volume":"83","author":"KM Cresswell","year":"2007","unstructured":"Cresswell KM, et al. Adverse drug events in the older adult. Br Med Bull. 2007;83(1):259\u201374.","journal-title":"Br Med Bull"},{"issue":"2","key":"5515_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4103\/0976-500X.110872","volume":"4","author":"DK Brahma","year":"2013","unstructured":"Brahma DK, et al. Adverse drug reactions in the older adult. J Pharmacol Pharmacotherapeutics. 2013;4(2):91\u20134.","journal-title":"J Pharmacol Pharmacotherapeutics"},{"issue":"3","key":"5515_CR5","doi-asserted-by":"publisher","first-page":"e33236","DOI":"10.1371\/journal.pone.0033236","volume":"7","author":"KM Hakkarainen","year":"2012","unstructured":"Hakkarainen KM, et al. Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions\u2013a meta-analysis. PLoS ONE. 2012;7(3):e33236.","journal-title":"PLoS ONE"},{"issue":"12","key":"5515_CR6","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1345\/aph.10094","volume":"34","author":"D-C Suh","year":"2000","unstructured":"Suh D-C, et al. Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann Pharmacother. 2000;34(12):1373\u20139.","journal-title":"Ann Pharmacother"},{"key":"5515_CR7","unstructured":"Organization WH. International drug monitoring: the role of national centers, report of a WHO meeting [held in Geneva from 20 to 25 September 1971]. World Health Organization; 1972."},{"key":"5515_CR8","unstructured":"World Health Organization, Quality A. and T. Safety of Medicines. Safety of medicines: a guide to detecting and reporting adverse drug reactions: why health professionals need to take action. 2002; https:\/\/policycommons.net\/artifacts\/590048\/safety-of-medicines\/"},{"issue":"1","key":"5515_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","volume":"57","author":"AA Mangoni","year":"2004","unstructured":"Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6\u201314.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"5515_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1517\/14740338.2013.827660","volume":"13","author":"RL Maher","year":"2014","unstructured":"Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in older adult. Expert Opin Drug Saf. 2014;13(1):57\u201365.","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"5515_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3906\/sag-2001-27","volume":"51","author":"F \u00c7inar","year":"2021","unstructured":"\u00c7inar F, Parlak G, Eti F, Aslan. The effect of comorbidity on mortality in older adult patients undergoing emergency abdominal surgery: a systematic review and meta-analysis. Turk J Med Sci. 2021;51(1):61\u20137.","journal-title":"Turk J Med Sci"},{"key":"5515_CR12","first-page":"p723678","volume":"2012","author":"PA Jansen","year":"2012","unstructured":"Jansen PA. J.R. Brouwers 2012 Clinical pharmacology in old persons. Scientifica (Cairo) 2012 p723678.","journal-title":"Scientifica (Cairo)"},{"issue":"6","key":"5515_CR13","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1093\/ageing\/afaa188","volume":"49","author":"EL Jennings","year":"2020","unstructured":"Jennings EL, et al. In-hospital adverse drug reactions in older adults; prevalence, presentation, and associated drugs\u2014a systematic review and meta-analysis. Age Ageing. 2020;49(6):948\u201358.","journal-title":"Age Ageing"},{"issue":"1","key":"5515_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/2042098615615472","volume":"7","author":"AH Lavan","year":"2016","unstructured":"Lavan AH. Gallagher Predicting risk of adverse drug reactions in older adults. Therapeutic Adv drug Saf. 2016;7(1):11\u201322.","journal-title":"Therapeutic Adv drug Saf"},{"issue":"31\u201332","key":"5515_CR15","first-page":"543","volume":"107","author":"S Holt","year":"2010","unstructured":"Holt S, Schmiedl S, Th\u00fcrmann PA. Potentially inappropriate medications in the older adult: the PRISCUS list. Deutsches \u00c4rzteblatt International. 2010;107(31\u201332):543.","journal-title":"Deutsches \u00c4rzteblatt International"},{"issue":"11","key":"5515_CR16","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","volume":"63","author":"A Panel","year":"2015","unstructured":"Panel A, et al. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227\u201346.","journal-title":"J Am Geriatr Soc"},{"key":"5515_CR17","first-page":"669","volume":"29","author":"B Tangiisuran","year":"2012","unstructured":"Tangiisuran B, et al. Adverse drug reactions in a population of hospitalized very older adult patients. Drugs Aging. 2012;29:669\u201379.","journal-title":"Drugs Aging"},{"issue":"2","key":"5515_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1046\/j.1365-2125.2003.01875.x","volume":"57","author":"PA Routledge","year":"2004","unstructured":"Routledge PA, O\u2019Mahony MS, Woodhouse KW. Adverse drug reactions in older adult patients. Br J Clin Pharmacol. 2004;57(2):121\u20136.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"5515_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s41999-021-00481-9","volume":"12","author":"MB Zazzara","year":"2021","unstructured":"Zazzara MB, et al. Adverse drug reactions in older adults: a narrative review of the literature. Eur Geriatr Med. 2021;12(3):463\u201373.","journal-title":"Eur Geriatr Med"},{"issue":"10","key":"5515_CR20","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1111\/bcp.14824","volume":"87","author":"S Ali","year":"2021","unstructured":"Ali S, et al. Pharmacist-led interventions to reduce adverse drug events in older people living in residential aged care facilities: a systematic review. Br J Clin Pharmacol. 2021;87(10):3672\u201389.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"5515_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1001\/jama.1997.03540280045032","volume":"277","author":"DW Bates","year":"1997","unstructured":"Bates DW, et al. The costs of adverse drug events in hospitalized patients. JAMA. 1997;277(4):307\u201311.","journal-title":"JAMA"},{"key":"5515_CR22","doi-asserted-by":"crossref","unstructured":"Al-Onazi M, et al. 64 The impact of collaboration between physicians, nurses, and clinical pharmacists in reducing medication prescribing errors in King Abdullah Specialized Children\u2019s Hospital ER. British Medical Journal Publishing Group; 2019.","DOI":"10.1136\/bmjoq-2019-PSF.64"},{"issue":"6","key":"5515_CR23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130(6):461\u201370.","journal-title":"Ann Intern Med"},{"issue":"6","key":"5515_CR24","first-page":"538","volume":"27","author":"G Schumock","year":"1992","unstructured":"Schumock G, Thornton J. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992;27(6):538\u2013538.","journal-title":"Hosp Pharm"},{"issue":"2","key":"5515_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239\u201345.","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"5515_CR26","first-page":"2229","volume":"49","author":"SC Hartwig","year":"1992","unstructured":"Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49(9):2229\u201332.","journal-title":"Am J Hosp Pharm"},{"issue":"8","key":"5515_CR27","first-page":"141","volume":"78","author":"E Kose","year":"2023","unstructured":"Kose E, et al. Pharmacist interventions for adverse drug reactions in Palliative Care: a Multicentre Pilot Study. Die Pharmazie-An Int J Pharm Sci. 2023;78(8):141\u20139.","journal-title":"Die Pharmazie-An Int J Pharm Sci"},{"issue":"2","key":"5515_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jsps.2013.02.003","volume":"22","author":"MJ Alomar","year":"2014","unstructured":"Alomar MJ. Factors affecting the development of adverse drug reactions (review article). Saudi Pharm J. 2014;22(2):83\u201394.","journal-title":"Saudi Pharm J"},{"key":"5515_CR29","doi-asserted-by":"publisher","first-page":"100611","DOI":"10.1016\/j.curtheres.2020.100611","volume":"93","author":"T Sahilu","year":"2020","unstructured":"Sahilu T, et al. Adverse drug events and contributing factors among hospitalized adult patients at Jimma Medical Center, Southwest Ethiopia: a prospective observational study. Curr Therapeutic Res. 2020;93:100611.","journal-title":"Curr Therapeutic Res"},{"issue":"9","key":"5515_CR30","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/pds.4966","volume":"29","author":"M Khalili","year":"2020","unstructured":"Khalili M, et al. Interventions to improve adverse drug reaction reporting: a scoping review. Pharmacoepidemiol Drug Saf. 2020;29(9):965\u201392.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"5515_CR31","unstructured":"Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: the patient-centered approach to medication management. McGraw-Hill Medical New York; 2012."},{"key":"5515_CR32","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/s11096-020-01150-w","volume":"43","author":"E Schindler","year":"2021","unstructured":"Schindler E, Richling I, Rose O. Pharmaceutical Care Network Europe (PCNE) drug-related problem classification version 9.00: German translation and validation. Int J Clin Pharm. 2021;43:726\u201330.","journal-title":"Int J Clin Pharm"},{"issue":"10","key":"5515_CR33","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1111\/imj.13961","volume":"48","author":"S Ognibene","year":"2018","unstructured":"Ognibene S, et al. Hospitalisation and morbidity due to adverse drug reactions in older adult patients: a single-centre study. Intern Med J. 2018;48(10):1192\u20137.","journal-title":"Intern Med J"},{"issue":"9","key":"5515_CR34","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/jama.289.9.1107","volume":"289","author":"JH Gurwitz","year":"2003","unstructured":"Gurwitz JH, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107\u201316.","journal-title":"JAMA"},{"issue":"2","key":"5515_CR35","doi-asserted-by":"publisher","first-page":"e0282096","DOI":"10.1371\/journal.pone.0282096","volume":"18","author":"AK Sendekie","year":"2023","unstructured":"Sendekie AK, et al. Incidence and patterns of adverse drug reactions among adult patients hospitalized in the University of Gondar comprehensive specialized hospital: a prospective observational follow-up study. PLoS ONE. 2023;18(2):e0282096.","journal-title":"PLoS ONE"},{"key":"5515_CR36","doi-asserted-by":"crossref","unstructured":"Kiguba R, Karamagi C, Bird SM. Incidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatients. BMJ Open, 2017. 7(1).","DOI":"10.1136\/bmjopen-2015-010568"},{"issue":"8","key":"5515_CR37","doi-asserted-by":"publisher","first-page":"e71045","DOI":"10.1371\/journal.pone.0071045","volume":"8","author":"JE Klopotowska","year":"2013","unstructured":"Klopotowska JE, et al. Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy. PLoS ONE. 2013;8(8):e71045.","journal-title":"PLoS ONE"},{"key":"5515_CR38","doi-asserted-by":"publisher","first-page":"767","DOI":"10.2165\/00002512-200522090-00005","volume":"22","author":"MCG Passarelli","year":"2005","unstructured":"Passarelli MCG, Jacob-Filho W, Figueras A. Adverse drug reactions in an older adult hospitalized population: inappropriate prescription is a leading cause. Drugs Aging. 2005;22:767\u201377.","journal-title":"Drugs Aging"},{"issue":"1","key":"5515_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/2042098617736191","volume":"9","author":"A Lavan","year":"2018","unstructured":"Lavan A, et al. Incident adverse drug reactions in geriatric inpatients: a multicentre observational study. Therapeutic Adv Drug Saf. 2018;9(1):13\u201323.","journal-title":"Therapeutic Adv Drug Saf"},{"issue":"4","key":"5515_CR40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jsps.2022.01.021","volume":"30","author":"B Alshehail","year":"2022","unstructured":"Alshehail B, et al. Incidence and risk factors of adverse drug reactions in patients with coronavirus disease 2019: a pharmacovigilance experience utilizing an ADR trigger tool. Saudi Pharm J. 2022;30(4):407\u201313.","journal-title":"Saudi Pharm J"},{"issue":"5","key":"5515_CR41","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1248\/bpb.b18-00820","volume":"42","author":"T Tachi","year":"2019","unstructured":"Tachi T, et al. Analysis of adverse reactions caused by potentially inappropriate prescriptions and related medical costs that are avoidable using the Beers criteria: the Japanese Version and Guidelines for Medical Treatment and its safety in the older adult 2015. Biol Pharm Bull. 2019;42(5):712\u201320.","journal-title":"Biol Pharm Bull"},{"key":"5515_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00228-016-2136-8","volume":"73","author":"D Sevilla-Sanchez","year":"2017","unstructured":"Sevilla-Sanchez D, et al. Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admission. Eur J Clin Pharmacol. 2017;73:79\u201389.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"5515_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40360-020-00464-9","volume":"21","author":"S-D Woo","year":"2020","unstructured":"Woo S-D, et al. Common causes and characteristics of adverse drug reactions in older adults: a retrospective study. BMC Pharmacol Toxicol. 2020;21(1):1\u20139.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"1","key":"5515_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40360-022-00570-w","volume":"23","author":"TA Ersulo","year":"2022","unstructured":"Ersulo TA, Yizengaw MA, Tesfaye BT. Incidence of adverse drug events in patients hospitalized in the medical wards of a teaching referral hospital in Ethiopia: a prospective observational study. BMC Pharmacol Toxicol. 2022;23(1):1\u201312.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"4","key":"5515_CR45","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1445-5994.2001.00044.x","volume":"31","author":"M Chan","year":"2001","unstructured":"Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the older adult. Intern Med J. 2001;31(4):199\u2013205.","journal-title":"Intern Med J"},{"issue":"4","key":"5515_CR46","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jsps.2013.06.004","volume":"22","author":"M Shamna","year":"2014","unstructured":"Shamna M, et al. A prospective study on adverse drug reactions of antibiotics in a tertiary care hospital. Saudi Pharm J. 2014;22(4):303\u20138.","journal-title":"Saudi Pharm J"},{"issue":"2","key":"5515_CR47","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/1574886311666160225150106","volume":"11","author":"JV Peter","year":"2016","unstructured":"Peter JV, et al. Patterns of adverse drug reaction in the medical wards of a Teaching Hospital: a prospective Observational Cohort Study. Curr Drug Saf. 2016;11(2):164\u201371.","journal-title":"Curr Drug Saf"},{"issue":"10","key":"5515_CR48","doi-asserted-by":"publisher","first-page":"e0205426","DOI":"10.1371\/journal.pone.0205426","volume":"13","author":"D Wolfe","year":"2018","unstructured":"Wolfe D, et al. Incidence, causes, and consequences of preventable adverse drug reactions occurring in inpatients: a systematic review of systematic reviews. PLoS ONE. 2018;13(10):e0205426.","journal-title":"PLoS ONE"},{"issue":"10","key":"5515_CR49","doi-asserted-by":"publisher","first-page":"e0186631","DOI":"10.1371\/journal.pone.0186631","volume":"12","author":"MT Angamo","year":"2017","unstructured":"Angamo MT, et al. Predictors of adverse drug reaction-related hospitalization in Southwest Ethiopia: a prospective cross-sectional study. PLoS ONE. 2017;12(10):e0186631.","journal-title":"PLoS ONE"},{"key":"5515_CR50","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.vascn.2016.04.011","volume":"81","author":"MI Geer","year":"2016","unstructured":"Geer MI, et al. Frequency, types, severity, preventability and costs of adverse drug reactions at a tertiary care hospital. J Pharmacol Toxicol Methods. 2016;81:323\u201334.","journal-title":"J Pharmacol Toxicol Methods"},{"key":"5515_CR51","doi-asserted-by":"crossref","unstructured":"Yu N et al. Adverse drug events in Chinese elder inpatients: a retrospective review for evaluating the efficiency of the global trigger Tool. Front Med, 2023. 10.","DOI":"10.3389\/fmed.2023.1232334"},{"issue":"2","key":"5515_CR52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5455\/njppp.2012.2.113-122.","volume":"2","author":"R Shah","year":"2012","unstructured":"Shah R, Gajjar B, Desai S. A profile of adverse drug reactions with risk factors among geriatric patients in a tertiary care teaching rural hospital in India. Natl J Physiol Pharm Pharmacol. 2012;2(2):113.","journal-title":"Natl J Physiol Pharm Pharmacol"},{"issue":"1","key":"5515_CR53","first-page":"M59","volume":"53A","author":"SL Gray","year":"1998","unstructured":"Gray SL, et al. Adverse drug events in hospitalized older adult. Journals Gerontology: Ser A. 1998;53A(1):M59\u201364.","journal-title":"Journals Gerontology: Ser A"},{"issue":"728","key":"5515_CR54","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.3399\/BJGP.2022.0181","volume":"73","author":"AS Doherty","year":"2023","unstructured":"Doherty AS, et al. Adverse drug reactions and associated patient characteristics in older community-dwelling adults: a 6-year prospective cohort study. Br J Gen Pract. 2023;73(728):e211\u20139.","journal-title":"Br J Gen Pract"},{"key":"5515_CR55","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2165\/00002512-200926060-00004","volume":"26","author":"P Olivier","year":"2009","unstructured":"Olivier P, et al. Hospitalizations because of adverse drug reactions in older adult patients admitted through the emergency department: a prospective survey. Drugs Aging. 2009;26:475\u201382.","journal-title":"Drugs Aging"},{"key":"5515_CR56","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s11096-017-0473-z","volume":"39","author":"TP de Figueiredo","year":"2017","unstructured":"de Figueiredo TP, et al. Factors associated with adverse drug reactions in older inpatients in a teaching hospital. Int J Clin Pharm. 2017;39:679\u201385.","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"5515_CR57","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/scipharm88040041","volume":"88","author":"ACF Modesto","year":"2020","unstructured":"Modesto ACF, et al. Prevalence of adverse drug events in severely obese adults and associated factors: clinical trial baseline results. Sci Pharm. 2020;88(4):41.","journal-title":"Sci Pharm"},{"key":"5515_CR58","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3389\/fphar.2018.00350","volume":"9","author":"C Giardina","year":"2018","unstructured":"Giardina C, et al. Adverse drug reactions in hospitalized patients: results of the FORWARD (facilitation of reporting in Hospital Ward) Study. Front Pharmacol. 2018;9:350.","journal-title":"Front Pharmacol"},{"issue":"1","key":"5515_CR59","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.amjopharm.2006.03.002","volume":"4","author":"JK Nguyen","year":"2006","unstructured":"Nguyen JK, et al. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother. 2006;4(1):36\u201341.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"1","key":"5515_CR60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/157488607779315507","volume":"2","author":"EC Davies","year":"2007","unstructured":"Davies EC, et al. Adverse drug reactions in hospitals: a narrative review. Curr Drug Saf. 2007;2(1):79\u201387.","journal-title":"Curr Drug Saf"},{"issue":"5","key":"5515_CR61","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/j.1365-2125.2010.03751.x","volume":"70","author":"EC Davies","year":"2010","unstructured":"Davies EC, et al. Emergency re-admissions to hospital due to adverse drug reactions within 1 year of the index admission. Br J Clin Pharmacol. 2010;70(5):749\u201355.","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"5515_CR62","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1177\/10781552211040736","volume":"28","author":"SS Salmany","year":"2022","unstructured":"Salmany SS, et al. Descriptive study of clinical pharmacist interventions in adult hospice and palliative care at a comprehensive oncology center in Jordan. J Oncol Pharm Pract. 2022;28(8):1749\u201353.","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"5515_CR63","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1517\/14740338.2013.827660","volume":"13","author":"RL Maher","year":"2014","unstructured":"Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in older adult. Exp Opin Drug Saf. 2014;13(1):57\u201365.","journal-title":"Exp Opin Drug Saf"},{"issue":"2","key":"5515_CR64","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0002-9343(00)00451-4","volume":"109","author":"JH Gurwitz","year":"2000","unstructured":"Gurwitz JH, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med. 2000;109(2):87\u201394.","journal-title":"Am J Med"},{"issue":"5","key":"5515_CR65","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","volume":"175","author":"IA Scott","year":"2015","unstructured":"Scott IA, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827\u201334.","journal-title":"JAMA Intern Med"},{"issue":"12","key":"5515_CR66","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1046\/j.1532-5415.2002.50607.x","volume":"50","author":"G Onder","year":"2002","unstructured":"Onder G, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the older adult (GIFA). J Am Geriatr Soc. 2002;50(12):1962\u20138.","journal-title":"J Am Geriatr Soc"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-05515-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-024-05515-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-05515-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T21:31:30Z","timestamp":1731792690000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-024-05515-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5515"],"URL":"https:\/\/doi.org\/10.1186\/s12877-024-05515-y","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,16]]},"assertion":[{"value":"27 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical review committee of Debre Tabor University\u2019s College of Health Science, Department of Pharmacy has approved ethical authorization with reference number 058\/2023. A support letter was sent to each of the four comprehensive hospitals. The directors of those healthcare organizations were then asked to sign a letter approving the usage of patient records as a source of data. Participants were informed about the purpose and design of the study before data collection. Furthermore, they provided their official consent to participate in the research. Written informed consent was obtained from all the study participants. Patients\u2019 medical registration numbers (MRNs) were swapped out for new codes during the data collecting and entry process. Besides, to protect its confidentiality, the gathered data was similarly kept in a locked cabinet and on a computer with a strong password. The study followed Helsinki legislation in terms of doing it in a properly anonymous and confidential manner.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"955"}}